Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)

NCT01004432 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

433

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis
Arthritis, Rheumatoid
Autoimmune Diseases

Interventions

DRUG: Golimumab 50 mg SC
DRUG: Golimumab 2 mg/kg IV
DRUG: Methotrexate (MTX)
DRUG: Placebo SC
DRUG: Placebo IV

Sponsor

Janssen Biotech, Inc.

Collaborators

[object Object]